presented to its investors. Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing highly selective molecular glue degrader (MGD) medicines targeting serious ...
Intermap’s CEO Patrick A. Blott, CFO Jennifer Bakken and COO Jack Schneider will host a live webinar on Thursday, November 14, 2024, at 4:30 pm ET / 2:30 pm MT to review the results, provide Company ...